On Wednesday, July 5, 2023, the ICAP-HICCC Cancer Initiative Webinar Series featured a presentation by Timothy R. Rebbeck, Vincent L. Gregory Professor of Cancer Prevention at the Harvard TH Chan School of Public Health and the Dana-Farber Cancer Institute. He discussed global cancer prevention from a molecular epidemiological perspective, including research on prostate cancer and the genetic, molecular, and epidemiological factors associated with risks, outcomes, and disparities of the disease.

Timothy R. Rebbeck, PhD, is the Vincent L. Gregory Professor of Cancer Prevention at the Harvard TH Chan School of Public Health and the Dana-Farber Cancer Institute.

Professor Rebbeck studies the etiology and prevention of cancer, with an emphasis on cancer disparities and global health. He has directed large, multicenter studies and international consortia that have identified genetic, molecular, and epidemiological factors associated with cancer risks, outcomes, and disparities. In addition, he leads the international Men of African Descent and Carcinoma of the Prostate (MADCaP) network and has led several consortia studying hereditary cancer risk and prevention. Dr. Rebbeck has received continuous federal research funding since 1994.

In addition to his research activities, Professor Rebbeck leads several initiatives on the Harvard Campus. He is Associate Director for Cancer Equity and Engagement at the Dana-Farber / Harvard Cancer Center. He is the founding director of the Zhu Family Center for Cancer Prevention at the Harvard TH Chan School of Public Health and Director of the Center for Global Health at Dana-Farber Cancer Institute. In these roles, he fosters a variety of cancer research and educational activities to ensure that Harvard research engages with and positively impacts communities with the most significant disease burden worldwide.